SCHEMBL1129961

SCHEMBL1129961

CCCCCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O

nearest known ligand 0.88

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ NAA50 Q9GZZ1 2/20 0.85
▸ CHAT P28329 2/20 0.82
▸ EP300 Q09472 3/20 0.80
▸ KAT5 Q92993 2/20 0.80
▸ AURKA O14965 2/20 0.80
▸ KAT2B Q92831 1/20 0.80
▸ CREBBP Q92793 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL366095 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA
Dodecanoyl-Coa SCHEMBL4309283 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA
SCHEMBL2934083 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA
SCHEMBL1756475 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA
Decanoyl-Coa SCHEMBL24667667 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA
Octanoyl-Coa SCHEMBL24667663 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA
SCHEMBL11027446 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA
Octanoyl-Coa SCHEMBL2370508 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA
SCHEMBL20970006 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA
Dodecanoyl-Coa SCHEMBL187868 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11268110-B2 Methods and materials for the enzymatic conversion of a non-3-enal to azelaic acid INV NYLON CHEMICALS AMERICAS, LLC (US) 2022-03-08 — — US claimed
US-20200277634-A1 METHODS AND MATERIALS FOR PRODUCING 7-CARBON MONOMERS Invista North America S.á.r.l. (US) 2020-09-03 — — US claimed
WO-2017136344-A1 PROCESS FOR PRODUCING C7 COMPOUNDS STARTING FROM 9-HYDROPEROXIDIZED LINOLEIC ACID INVISTA North America S.à.r.l. (US) 2017-08-10 — — WO claimed
US-20170218406-A1 Methods and Materials for Producing 7-Carbon Monomers INVISTA NORTH AMERICA S.A.R.L. (US) 2017-08-03 — — US claimed
US-20240287555-A1 METHODS AND YEAST CELLS FOR PRODUCTION OF DESATURATED COMPOUNDS FMC Agricultural Solutions A/S (DK) 2024-08-29 — — US disclosed
US-20240279693-A1 METHODS AND YEAST CELLS FOR PRODUCTION OF DESATURATED COMPOUNDS FMC Agricultural Solutions A/S (DK) 2024-08-22 — — US disclosed
EP-4363562-A1 METHODS AND YEAST CELLS FOR PRODUCTION OF DESATURATED COMPOUNDS FMC Agricultural Solutions A/S (DK) 2024-05-08 — — EP disclosed
EP-4363561-A1 METHODS AND YEAST CELLS FOR PRODUCTION OF DESATURATED COMPOUNDS FMC Agricultural Solutions A/S (DK) 2024-05-08 — — EP disclosed
CN-117916363-A Method for producing desaturated compounds and yeast cells 富美实农业解决方案公司 2024-04-19 — — CN disclosed
WO-2023275361-A1 METHODS AND YEAST CELLS FOR PRODUCTION OF DESATURATED COMPOUNDS BIOPHERO APS (DK) 2023-01-05 — — WO disclosed
WO-2023275374-A1 METHODS AND YEAST CELLS FOR PRODUCTION OF DESATURATED COMPOUNDS BIOPHERO APS (DK) 2023-01-05 — — WO disclosed
US-20220288004-A1 TREATMENT AND PREVENTION OF AGING RELATED-DISEASE AND/OR AGING BY THE INHIBITION OF SPHINGOLIPIDS ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2022-09-15 — — US disclosed
US-20110124071-A1 METHODS AND COMPOSITIONS FOR PRODUCING HYDROCARBONS LS9, Inc (US) 2011-05-26 — — US disclosed
EP-2288694-A1 METHODS AND COMPOSITIONS FOR PRODUCING HYDROCARBONS LS9, Inc. (US) 2011-03-02 — — EP disclosed
EP-2283121-A2 METHODS AND COMPOSITIONS FOR PRODUCING HYDROCARBONS LS9, Inc. (US) 2011-02-16 — — EP disclosed
US-20100249470-A1 METHODS AND COMPOSITIONS FOR PRODUCING HYDROCARBONS LS9, INC. (US) 2010-09-30 — — US disclosed
US-20100221798-A1 METHODS AND COMPOSITIONS FOR PRODUCING HYDROCARBONS LS9, INC. (US) 2010-09-02 — — US disclosed
WO-2009140695-A1 METHODS AND COMPOSITIONS FOR PRODUCING HYDROCARBONS LS9, INC. (US) 2009-11-19 — — WO disclosed
WO-2009140696-A2 METHODS AND COMPOSITIONS FOR PRODUCING HYDROCARBONS LS9, INC. (US) 2009-11-19 — — WO disclosed
US-20060147899-A1 Multicellular metabolic models and methods GENOMATICA, INC. 2006-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220288004-A1 TREATMENT AND PREVENTION OF AGING RELATED-DISEASE AND/OR AGING BY THE INHIBITION OF SPHINGOLIPIDS SMPD3, SMPD2, SMPD1 NAA50 567/4885CHAT 522/4885EP300 850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback